NEW YORK (GenomeWeb) – What makes next-generation sequencing-based diagnostic tests alluring also makes them complicated to regulate, but changes to the regulatory framework could ease the adoption of such tests, the Broad Institute's Eric Lander wrote in a Perspective article in the New England Journal of Medicine this week.
Menu
In NEJM, Lander Lauds Steps at FDA to Build New Regulatory Framework for Genomic Tests
Feb 18, 2015
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.